Specialized Bilayer Tablets for Extreme Environments and High-Risk Applications

Publication ID: 24-11857684_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Bilayer Tablets for Extreme Environments and High-Risk Applications,” Published Technical Disclosure No. 24-11857684_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857684_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,684.

Summary of the Inventive Concept

The present inventive concept discloses novel bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, specifically designed for high-altitude environments, disaster relief, extreme weather conditions, and high-security needs. These tablets provide rapid relief from cold and flu symptoms in challenging operational environments.

Background and Problem Solved

The original patent disclosed bilayer tablets comprising acetylsalicylic acid and pseudoephedrine. However, these tablets may not be suitable for use in extreme environments, such as high-altitude areas, disaster zones, or areas with limited access to medical care. The present inventive concept addresses these limitations by adapting the bilayer tablets for specific, narrow markets or unique operational environments.

Detailed Description of the Inventive Concept

The inventive concept comprises bilayer tablets with acetylsalicylic acid and pseudoephedrine, formulated to mitigate degradation at low atmospheric pressure, packaged in waterproof containers, coated with water-resistant layers, or integrated with water purification systems. The tablets may also be packaged in high-security containers with tamper-evident seals and GPS tracking devices. These specialized tablets provide rapid relief from cold and flu symptoms in challenging operational environments, ensuring optimal performance and efficacy.

Novelty and Inventive Step

The present inventive concept introduces novel and non-obvious adaptations of the original bilayer tablets for specific, narrow markets or unique operational environments. The inventive step lies in the combination of the original bilayer tablet composition with specialized formulations, packaging, and integration with other systems to address the unique challenges of high-altitude environments, disaster relief, extreme weather conditions, and high-security needs.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include bilayer tablets with modified release profiles, additional active pharmaceutical ingredients, or different excipients tailored for specific environments or applications. Variations may also include different packaging materials, shapes, or sizes to accommodate specific operational requirements.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of disaster relief, high-security operations, and extreme environment exploration. Target industries may include government agencies, humanitarian organizations, and private companies operating in challenging environments.

CPC Classifications

SectionClassGroup
A A61 A61K9/209
A A61 A61J3/10
A A61 A61K31/137
A A61 A61K31/616
A A61 A61K9/2009
A A61 A61K9/2018
A A61 A61K9/2054
A A61 A61K9/2059

Original Patent Information

Patent NumberUS 11,857,684
TitleOral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof
Assignee(s)BAYER AKTIENGESELLSCHAFT